Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

This idea in IP3

https://ip3.pistoiaalliance.org/subdomain/main/end/node/2055

Meeting Minutes

2019.09.06 Initial Meeting

Meeting Minutes and Project Files



Publication References

  • Add here and supply links

Project members:

Dan Szot Cambridge SemanticsJames LapointeCambridge SemanticsPhilip GillissenBayerStefan RatzkeBayerDave KingBayerBrandon Allgood NumerateAndras Stracz ChemAxonHerbert LinShireGreg LandrumKnimeFrederik van den BroekElsevierJulio Cesar Bolivar LopezBayerTerry StouchScience For SolutionsSven-Eric SchelhornMerck KgaLingling ShenNovartisEdward OakeleyNovartisShantanu SinghBroad InstituteNick LynchPistoia AllianceCarmen NitschePistoia Alliance

Summary of Our Paper in Drug Discovery Today ("The 11 Commandments")

  1. DS is not enough: domain knowledge is a must
  2. Quality data (…and metadata) à quality models
  3. Long-term data management methodology, e.g. FAIR for life cycle planning for scientific data
  4. Publish model code, and testing and training data, sufficient for reproduction of research work, along with model results
  5. Use model management system
  6. Use ML methods fit for problem class
  7. Manage executive expectations
  8. Educate your colleagues – leaders in particular
  9. AI models + humans-in-the-loop à “AI-in-the-loop” (Chas Nelson invented the term)
  10. Experiment and fail fast if needed. A bad ML model that is quickly deemed worthless is better than a deceptive model
  11. Maintain an Innovation Center for moonshot-type technology programs (this COE is an example of one)

Vladimir A. Makarov, Terry Stouch, Brandon Allgood, Chris D. Willis, Nick Lynch, "Best practices for artificial intelligence in life sciences research", Drug Discovery Today, Volume 26, Issue 5, 2021, Pages 1107-1110, ISSN 1359-6446, https://doi.org/10.1016/j.drudis.2021.01.017.  Free pre-print available at https://osf.io/eqm9j/
Abstract: We describe 11 best practices for the successful use of artificial intelligence and machine learning in pharmaceutical and biotechnology research at the data, technology and organizational management levels. 

Walsh, I., Fishman, D., Garcia-Gasulla, D. et al. DOME: recommendations for supervised machine learning validation in biology. Nat Methods 18, 1122–1127 (2021). https://doi.org/10.1038/s41592-021-01205-4

Project members:


Fotis

Psomopoulos

CERTH

Brandon

Allgood

Valo Health

Christophe

Chabbert

Roche

Adrian

Schreyer

Exscientia

Elina

Koletou

Roche

Frederik

van der Broek

f.broek@elsevier.com

David

Wöhlert 

D.Woehlert@elsevier.com

John

Overington

Exscientia

Loganathan

Kumarasamy

Zifo R&D





Neal

Dunkinson

Scibite

Simon

Thornber

GSK

Irene

Pak

BMS

Berenice

Wullbrecht

berenice.wulbrecht@ontoforce.com

Prashant

Natarajan

prashant.natarajan@h2o.ai

Valerie

Morel

valerie.morel@ontoforce.com

Yvonna

Li

yvonna.li@roche.com

Silvio

Tosatto

silvio.tosatto@unipd.it

Natalja

Kurbatova

Natalja.Kurbatova@zifornd.com

Mufis

Thalath

Mufis.M@zifornd.com

Niels

Van Beuningen

niels.vanbeuningen@vivenics.com

Ton

Van Daelen

ton.vandaelen@3ds.com

Lucille

Valentine

lucille@gliff.ai

Adrian

Fowkes

adrian.fowkes@lhasalimited.org

Chas

Nelson

Chas@gliff.ai

Paolo

Simeone

paolo.simeone@ontoforce.com

Vladimir

Makarov

Vladimir.makarov@pistoiaalliance.org